• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学检查结果和血清甲胎蛋白水平在产甲胎蛋白胃癌预后中的作用。

Roles of histological findings and serum AFP levels in the prognosis of AFP-producing gastric cancers.

作者信息

Uefuji K, Ichikura T, Tamakuma S

机构信息

First Department of Surgery, National Defense Medical College, Saitama.

出版信息

Jpn J Clin Oncol. 1994 Jun;24(3):135-40.

PMID:7516444
Abstract

We investigated the roles of histological findings and serum AFP levels in the prognosis of gastric cancers which produce AFP. We considered the typical features of such gastric cancers to be the medullary growth of undifferentiated cancer cells with clear, or slightly eosinophilic, abundant cytoplasm and pleomorphic large round nuclei, forming either papillary clear carcinomas or hepatoid carcinomas. Seventeen patients with AFP-producing gastric cancers were observed in the period, 1979-1991. They were divided into two groups: those with (n 5) and those without (n 12) the typical histological features mentioned above. Their clinicopathological findings and prognoses were compared. Both groups showed a male dominance, gross Borrmann's type 2 or 3 appearances, diagnoses made at an advanced stage and metastatic involvements of the liver. The patients with the typical histological features showed a significantly higher AFP serum level and a significantly shorter survival. The patients who lacked the typical findings, and with serum AFP levels > or = 100 ng/ml, had poorer prognoses, while those lacking the typical histological features, and serum AFP levels < 100 ng/ml had better prognoses. The combination of histological findings and serum AFP level appeared to be useful in predicting the prognosis of AFP-producing gastric cancers. Intensive adjuvant therapy, e.g., chemotherapy administered via hepatic arterial infusion, may be indicated for patients at a high risk of recurrence following curative surgery.

摘要

我们研究了组织学表现和血清甲胎蛋白(AFP)水平在产生AFP的胃癌预后中的作用。我们认为此类胃癌的典型特征是未分化癌细胞呈髓样生长,细胞质清晰或略嗜酸性、丰富,细胞核多形性、大而圆,形成乳头状透明癌或肝样癌。在1979年至1991年期间观察了17例产生AFP的胃癌患者。他们被分为两组:具有(n = 5)和不具有(n = 12)上述典型组织学特征的患者。比较了他们的临床病理表现和预后。两组均以男性居多,大体呈Borrmann 2型或3型外观,诊断时处于晚期且有肝转移。具有典型组织学特征的患者血清AFP水平显著更高,生存期显著更短。缺乏典型表现且血清AFP水平≥100 ng/ml的患者预后较差,而缺乏典型组织学特征且血清AFP水平<100 ng/ml的患者预后较好。组织学表现和血清AFP水平的结合似乎有助于预测产生AFP的胃癌的预后。对于根治性手术后复发风险高的患者,可能需要强化辅助治疗,例如通过肝动脉灌注进行化疗。

相似文献

1
Roles of histological findings and serum AFP levels in the prognosis of AFP-producing gastric cancers.组织学检查结果和血清甲胎蛋白水平在产甲胎蛋白胃癌预后中的作用。
Jpn J Clin Oncol. 1994 Jun;24(3):135-40.
2
[The characters of AFP-producing early gastric cancer].[产甲胎蛋白早期胃癌的特征]
Nihon Geka Gakkai Zasshi. 1990 Oct;91(10):1574-80.
3
Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.产生甲胎蛋白的胃癌细胞中血管内皮生长因子(VEGF)和血管内皮生长因子C(VEGF-C)表达的评估
J Gastroenterol. 2003;38(6):540-7. doi: 10.1007/s00535-002-1099-y.
4
Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.甲胎蛋白阳性胃癌的临床病理特征及预后因素分析:104 例病例分析。
J Surg Oncol. 2010 Sep 1;102(3):249-55. doi: 10.1002/jso.21624.
5
Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer.甲胎蛋白阳性胃癌行胃切除术的长期疗效。
Br J Surg. 2010 Jul;97(7):1056-61. doi: 10.1002/bjs.7081.
6
[Clinicopathological study of AFP producing gastric cancer--significance of AFP in gastric cancer].【产甲胎蛋白胃癌的临床病理研究——甲胎蛋白在胃癌中的意义】
Nihon Geka Gakkai Zasshi. 1987 Jun;88(6):696-700.
7
Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.甲胎蛋白(AFP)阳性胃癌的生物学侵袭性
Hepatogastroenterology. 2006 May-Jun;53(69):338-41.
8
Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.甲胎蛋白阳性与甲胎蛋白阴性胃癌的临床病理特征比较。
Am J Gastroenterol. 1992 Mar;87(3):321-5.
9
[Effective transcatheter arterial embolization for hepatic metastasis in a case of AFP producing gastric cancer].[经导管动脉栓塞术治疗甲胎蛋白分泌型胃癌肝转移的疗效分析]
Gan To Kagaku Ryoho. 1996 Oct;23(12):1705-8.
10
The potential for the development of liver metastasis from alpha-fetoprotein-producing human gastric carcinomas in nude mice.裸鼠中产生甲胎蛋白的人胃癌发生肝转移的可能性。
Jpn J Clin Oncol. 1992 Oct;22(5):303-7.

引用本文的文献

1
Alpha fetoprotein (AFP)-producing gastric cancer: clinicopathological features and treatment strategies.产生甲胎蛋白的胃癌:临床病理特征与治疗策略
Cell Biosci. 2025 Jun 10;15(1):82. doi: 10.1186/s13578-025-01424-8.
2
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.甲胎蛋白产生型胃癌的全外显子组测序揭示了基因组特征和治疗靶点。
Nat Commun. 2021 Jun 24;12(1):3946. doi: 10.1038/s41467-021-24170-0.
3
Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Differentiation.
伴有黏膜内肝样和胎儿肠型分化的产甲胎蛋白早期胃癌
Case Rep Gastroenterol. 2020 Aug 26;14(2):426-435. doi: 10.1159/000508413. eCollection 2020 May-Aug.
4
Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases.产甲胎蛋白的结直肠癌的临床病理特征及预后:20例单中心分析
Cancer Manag Res. 2019 May 16;11:4557-4567. doi: 10.2147/CMAR.S196919. eCollection 2019.
5
IMMUNOBIOLOGICAL MONITORING OF VARIOUS GASTROINTESTINAL AND PRIMARY HEPATIC MALIGNANCIES.各种胃肠道和原发性肝癌的免疫生物学监测
Med J Armed Forces India. 1997 Jul;53(3):178-182. doi: 10.1016/S0377-1237(17)30711-6. Epub 2017 Jun 26.
6
Prolonged Survival in a Case of Chemotherapy-Sensitive Gastric Cancer That Produced Alpha-Fetoprotein and Protein Induced by Vitamin K Antagonist-II.一例产生甲胎蛋白和维生素K拮抗剂-II诱导蛋白的化疗敏感性胃癌患者的长期生存
Case Rep Gastroenterol. 2015 Apr 24;9(1):113-9. doi: 10.1159/000382072. eCollection 2015 Jan-Apr.
7
Double cancer of the stomach, one AFP-producing tumor.胃双癌,其中一个为产生甲胎蛋白的肿瘤。
J Gastroenterol. 1996 Dec;31(6):851-4. doi: 10.1007/BF02358614.
8
Clinical and prognostic characteristics of papillary clear carcinoma of stomach.
Surg Today. 1996;26(3):158-63. doi: 10.1007/BF00311499.